Yahoo
    HKSE - Delayed Quote HKD

    SinoMab BioScience Limited (3681.HK)

    1.070 +0.050 (+4.90%)
    At close: October 30 at 4:08:06 PM GMT+8
    Loading Chart for 3681.HK
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Dow Jones Futures Loom After Market Sell-Off; How Midterm Elections May Swing Stocks

    Dow Jones Futures Loom After Market Sell-Off; How Midterm Elections May Swing Stocks
    Investor's Business Daily 1h ago
    5 must-read analyst questions from BrightSpring Health Services’s Q3 earnings call

    5 must-read analyst questions from BrightSpring Health Services’s Q3 earnings call
    StockStory 1h ago
    BioMarin Pharmaceutical (BMRN) Q3 earnings: what to expect

    BioMarin Pharmaceutical (BMRN) Q3 earnings: what to expect
    StockStory 1h ago
    Vertex Pharmaceuticals earnings: what to look for from VRTX

    Vertex Pharmaceuticals earnings: what to look for from VRTX
    StockStory 2h ago
    Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing

    Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing
    Motley Fool 2h ago
    Australian Stock Market Today: ASX Futures Dip On US Tech Selloff And RBA Decision

    Australian Stock Market Today: ASX Futures Dip On US Tech Selloff And RBA Decision
    Simply Wall St. 3h ago
    What Is BridgeBio Pharma (BBIO) Betting On With Three FDA Priority Launches?

    What Is BridgeBio Pharma (BBIO) Betting On With Three FDA Priority Launches?
    Simply Wall St. 3h ago
    1 Dividend-Paying Biotech Stock to Buy Hand Over Fist in November

    1 Dividend-Paying Biotech Stock to Buy Hand Over Fist in November
    Motley Fool 3h ago
    Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

    Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System
    PR Newswire 3h ago
    Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.

    Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
    Motley Fool 3h ago
    Learn Why The Bull Case For Cullinan Therapeutics (CGEM) Could Change Following Trial Clearance

    Learn Why The Bull Case For Cullinan Therapeutics (CGEM) Could Change Following Trial Clearance
    Simply Wall St. 4h ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: